The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, May 21, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for April 2025 the Company recorded decrease in sales of 28% compared to the same month of the previous year, incl. 19% decrease in domestic sales and 34% decrease in export sales.
For the period from the beginning of 2025, the Company realized a 3% increase in sales, including 7% decrease in domestic sales and a 11% increase in export sales.
